You are on page 1of 1

Patient Name : Mr.

RAJESH RANJAN [UHIDNO:FHP27115808042023]


Age / Gender : 29 Yr / Male UHIDNO:FHP271158080420
Address : NOIDA , Gautam Buddha Nagar, UTTAR PRADESH

Requesting Doctor: DR. PRIYANKA SINGH Reg. ID :OPD.23-24-40488

IMMUNOLOGY

Request Date : 15-07-2023 05:22 PM Reporting Date : 15-07-2023 07:00 PM


Collection Date : 15-07-2023 05:28 PM[IMMU26135] Reporting Status : Finalized
Acceptance Date : 15-07-2023 05:28 PM | TAT: 01:32
[HH:MM]

Investigations Method Result Biological Reference


VITAMIN D3 (25 HYDROXY) *[ Plain 34.79 nmol/L * 75.00 - 250.00 nmol/L
tube (red top) ] (Age 13 Y - 100 Y)
Performed On: ACCESS 2 (BECKMAN COULTER)
Reference Ranges:
Deficiency : <25 nmol/L
Insufficiency : 25 -75 nmol/L
Sufficiency : 75-250 nmol/L
Toxicity: >250 nmol/L
Clinical Significance: This test is used to determine the levels of 25-hydroxy-vitamin D and is used to determine if bone weakness, bone
malformation, or abnormal metabolism of calcium is occurring as a result of a deficiency or excess of vitamin D Since vitamin D is a fat-soluble
vitamin and is absorbed from the intestine like a fat, vitamin D is also s used to monitor individuals with diseases that interfere with fat absorption,
such as cystic fibrosis and Crohn's disease, and in patients who have had gastric bypass surgery and may not be able to absorb enough Vitamin
D Vitamin D is also used to determine effectiveness of treatment when vitamin D, calcium, phosphorus, and/or magnesium supplementation is
prescribed. Reasons for suboptimal 25-OH-VitD levels include lack of sunshine exposure, inadequate intake; malabsorption eg, due to Celiac
disease); depressed hepatic vitamin D 25-hydroxylase activity, secondary to advanced liver disease; and enzyme-inducing drugs, in particular
many antiepileptic drugs, including phenytoin, phenobarbital, and carbamazepine, that increase 25-OH-VitD metabolism. In contrast to the high
prevalence of 25-OH-VitD deficiency, hypervitaminosis D is rare, and is only seen after prolonged exposure to extremely high doses of vitamin D.
When it occurs, it can result in severe hypercalcemia and hyperphosphatemia.

Method : Fully Automated Chemi Luminescent Immuno Assay

Kindly correlate with clinical conditions

END OF REPORT.

Prepared By VAIBHAV TIWARI


PIYUSH SHUKLA MBBS, MD
(PATHOLOGY)

Page 1 of 1
Mr. RAJESH RANJAN / UHIDNO:FHP27115808042023 Printed By: POOJA
Regn No.: OPD.23-24-40488 16-07-2023 03:36 PM

You might also like